HR Execs on the Move

Cardium Therapeutics, Inc.

www.cardiumthx.com

 
Cardium Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in San Diego, CA. To find more information about Cardium Therapeutics, Inc., please visit www.cardiumthx.com
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.cardiumthx.com
  • 12255 El Camino Real Ste 250
    San Diego, CA USA 92130-4090
  • Phone: 858.436.1000

Executives

Name Title Contact Details

Similar Companies

Association of Clinicians for the Underserved

ACU is a nonprofit, transdisciplinary organization of clinicians, advocates and health care organizations united in a common mission to improve the health of America`s underserved populations and to enhance the development and support of the health care clinicians serving these populations.

VIDA MEDICAL GROUP, LA

VIDA MEDICAL GROUP, LA is a Lawndale, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Vets First Choice

We are the nation`s largest veterinary partner-pharmacy providing veterinarians with a custom online store so they can offer the best home delivery service for their clients. We offer pet owners a way to shop online with their own veterinarian in a safe and secure web store for their pet. Behind the scenes, we are the veterinarian`s fully-licensed and accredited veterinary pharmacy. We have direct partnerships with all of the manufacturers--so we don`t just guarantee that the products “are the same”...we 100% guarantee that all products have been handled properly to maintain their quality. That`s a big difference when it comes to the safety of a pet.

Vascular Access Teaching Aids

Vascular Access Teaching Aids is a Oregon City, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avexis Inc

AveXis is a clinic-ready, synthetic biology platform company. AveXis has, at its core, a desire to establish unique industry and research alliances which will bring innovative treatments to people with unmet medical needs. Our work in spinal muscular atrophy (SMA), a rare/orphan disease, is our first focus.